Ericka Moerman

1.5k total citations · 1 hit paper
19 papers, 1.2k citations indexed

About

Ericka Moerman is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ericka Moerman has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 11 papers in Genetics and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ericka Moerman's work include Pancreatic function and diabetes (16 papers), Diabetes and associated disorders (10 papers) and Metabolism, Diabetes, and Cancer (6 papers). Ericka Moerman is often cited by papers focused on Pancreatic function and diabetes (16 papers), Diabetes and associated disorders (10 papers) and Metabolism, Diabetes, and Cancer (6 papers). Ericka Moerman collaborates with scholars based in France, Belgium and Germany. Ericka Moerman's co-authors include François Pattou, Valéry Gmyr, Julie Kerr‐Conte, B. Vandewalle, Nathalie Delalleau, Bart Staels, Julien Thévenet, Caroline Bonner, Gurvan Quéniat and Bruno Lukowiak and has published in prestigious journals such as Nature Medicine, Diabetes and Biochemical Journal.

In The Last Decade

Ericka Moerman

19 papers receiving 1.2k citations

Hit Papers

Inhibition of the glucose transporter SGLT2 with dapaglif... 2015 2026 2018 2022 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ericka Moerman France 14 707 690 403 332 165 19 1.2k
Mariko Kajikawa Japan 18 402 0.6× 392 0.6× 354 0.9× 144 0.4× 72 0.4× 36 1.8k
Moufida Ben Nasr United States 19 485 0.7× 479 0.7× 293 0.7× 369 1.1× 29 0.2× 38 1.2k
Margaret Warren-Perry United Kingdom 15 210 0.3× 221 0.3× 315 0.8× 238 0.7× 152 0.9× 20 845
Karen E. Friday United States 14 297 0.4× 373 0.5× 179 0.4× 94 0.3× 76 0.5× 17 818
Elizabeth Rabbitt United Kingdom 17 173 0.2× 829 1.2× 232 0.6× 179 0.5× 55 0.3× 19 1.2k
Davide Nacamulli Italy 22 218 0.3× 944 1.4× 207 0.5× 175 0.5× 141 0.9× 39 1.2k
Paola Sindaco Italy 14 430 0.6× 743 1.1× 156 0.4× 280 0.8× 26 0.2× 28 970
Cecilia Hofmann United States 14 392 0.6× 359 0.5× 366 0.9× 269 0.8× 30 0.2× 19 927
Joaquim Calado Portugal 12 325 0.5× 461 0.7× 453 1.1× 131 0.4× 70 0.4× 31 824
Satoru Akazawa Japan 16 322 0.5× 284 0.4× 251 0.6× 248 0.7× 19 0.1× 46 965

Countries citing papers authored by Ericka Moerman

Since Specialization
Citations

This map shows the geographic impact of Ericka Moerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ericka Moerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ericka Moerman more than expected).

Fields of papers citing papers by Ericka Moerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ericka Moerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ericka Moerman. The network helps show where Ericka Moerman may publish in the future.

Co-authorship network of co-authors of Ericka Moerman

This figure shows the co-authorship network connecting the top 25 collaborators of Ericka Moerman. A scholar is included among the top collaborators of Ericka Moerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ericka Moerman. Ericka Moerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Saponaro, Chiara, Markus Mühlemann, Anthony Piron, et al.. (2020). Interindividual Heterogeneity of SGLT2 Expression and Function in Human Pancreatic Islets. Diabetes. 69(5). 902–914. 42 indexed citations
2.
Saponaro, Chiara, Valéry Gmyr, Julien Thévenet, et al.. (2019). The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release. Cell Reports. 28(6). 1447–1454.e4. 25 indexed citations
3.
Gmyr, Valéry, Caroline Bonner, Ericka Moerman, et al.. (2016). Human Recombinant Antithrombin (ATryn®) Administration Improves Survival and Prevents Intravascular Coagulation after Intraportal Islet Transplantation in a Piglet Model. Cell Transplantation. 26(2). 309–317. 5 indexed citations
4.
Bonner, Caroline, Julie Kerr‐Conte, Valéry Gmyr, et al.. (2015). Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nature Medicine. 21(5). 512–517. 538 indexed citations breakdown →
5.
Bonner, Caroline, Valéry Gmyr, Gurvan Quéniat, et al.. (2014). Glucose transporter SGLT2 inhibition triggers glucagon secretion in alpha cells. 5 indexed citations
6.
Lefebvre, Bruno, B. Vandewalle, Gurvan Quéniat, et al.. (2012). Regulation and functional effects of ZNT8 in human pancreatic islets. Journal of Endocrinology. 214(2). 225–232. 31 indexed citations
7.
Briand, Olivier, Audrey Helleboid‐Chapman, Maheul Ploton, et al.. (2012). The Nuclear Orphan Receptor Nur77 Is a Lipotoxicity Sensor Regulating Glucose-Induced Insulin Secretion in Pancreatic β-Cells. Molecular Endocrinology. 26(3). 399–413. 36 indexed citations
8.
Lefebvre, Bruno, B. Vandewalle, Ericka Moerman, et al.. (2010). Efficient gene delivery and silencing of mouse and human pancreatic islets. BMC Biotechnology. 10(1). 28–28. 13 indexed citations
9.
Kerr‐Conte, Julie, B. Vandewalle, Ericka Moerman, et al.. (2010). Upgrading Pretransplant Human Islet Culture Technology Requires Human Serum Combined With Media Renewal. Transplantation. 89(9). 1154–1160. 36 indexed citations
10.
Vandewalle, B., Ericka Moerman, Bruno Lefebvre, et al.. (2008). PPARγ-dependent and -independent effects of Rosiglitazone on lipotoxic human pancreatic islets. Biochemical and Biophysical Research Communications. 366(4). 1096–1101. 45 indexed citations
11.
Caïazzo, Robert, Valéry Gmyr, Thomas Hübert, et al.. (2007). Evaluation of Alternative Sites for Islet Transplantation in the Minipig: Interest and Limits of the Gastric Submucosa. Transplantation Proceedings. 39(8). 2620–2623. 41 indexed citations
12.
Hübert, Thomas, Ericka Moerman, Valéry Gmyr, et al.. (2007). In Vivo and In Vitro Effect of Sirolimus on Insulin Secretion. Transplantation. 83(5). 532–538. 31 indexed citations
13.
Vandewalle, B., Ericka Moerman, S Belaïch, et al.. (2006). 1,25-dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the fas receptor. APOPTOSIS. 11(2). 151–159. 120 indexed citations
14.
Bouckenooghe, Thomas, B. Vandewalle, Ericka Moerman, et al.. (2005). Expression of Progenitor Cell Markers During Expansion of Sorted Human Pancreatic Beta Cells. Gene Expression. 12(2). 83–98. 13 indexed citations
15.
Muharram, Ghaffar, Anthony Beucher, Ericka Moerman, et al.. (2005). Endocrine pancreatic tissue plasticity in obese humans is associated with cytoplasmic expression of PBX-1 in pancreatic ductal cells. Biochemical and Biophysical Research Communications. 333(4). 1153–1159. 8 indexed citations
17.
Eeckhoute, Jérôme, Ericka Moerman, Thomas Bouckenooghe, et al.. (2003). Hepatocyte Nuclear Factor 4α Isoforms Originated from the P1 Promoter Are Expressed in Human Pancreatic β-Cells and Exhibit Stronger Transcriptional Potentials than P2 Promoter-Driven Isoforms. Endocrinology. 144(5). 1686–1694. 74 indexed citations
19.
Vandewalle, B., Julie Kerr-Conte, Ericka Moerman, et al.. (2002). 1,25-Dihydroxyvitamin D3Protects RINm5F and Human Islet Cells against Cytokine-Induced Apoptosis: Implication of the Antiapoptotic Protein A20. Endocrinology. 143(12). 4809–4819. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026